Skip to main content
. 2023 May 2;30(3):176–184. doi: 10.4078/jrd.2023.0009

Table 2.

Comparisons of demographic variables, NP, FM, CSI-A, and CSI-B values between patients with axSpA and healthy controls

Variable axSpA (n=116) Control (n=95) All (n=211) p-value
Age (yr) 42.0±10.2 41.6±11.3 41.8±10.7 0.769
Sex 0.917
Male 59 (50.9) 49 (51.6) 108 (51.2)
Female 57 (49.1) 46 (48.4) 103 (48.8)
NP (DN4) <0.001*
Yes 27 (23.3) 5 (5.3) 32 (15.2)
No 89 (76.7) 90 (94.7) 179 (84.8)
FM <0.001*
Yes 28 (24.1) 6 (6.3) 34 (16.1)
No 88 (75.9) 89 (93.7) 177 (83.9)
CSI-A 38 (19.3~54.8) 23 (10~33) 28 (14~46) <0.001*
Presence of CS <0.001*
Yes ≥40 54 (46.6) 13 (13.7) 67 (31.8)
No <40 62 (53.4) 82 (86.3) 144 (68.2)
CSI-B, syndromes
FM syndrome 0.066
Yes 11 (9.5) 3 (3.2) 14 (6.6)
No 105 (90.5) 92 (96.8) 197 (93.4)
RL syndrome 0.151
Yes 9 (7.8) 3 (3.2) 12 (5.7)
No 107 (92.2) 92 (96.8) 199 (94.3)
CF syndrome 0.517
Yes 109 (94.0) 92 (96.8) 201 (95.3)
No 7 (6.0) 3 (3.2) 10 (4.7)
TMJ disorders 0.629
Yes 3 (2.6) 1 (1.1) 4 (1.9)
No 113 (97.4) 94 (98.9) 207 (98.1)
Migraine/TTH 0.587
Yes 19 (16.4) 13 (13.7) 32 (15.2)
No 97 (83.6) 82 (86.3) 179 (84.8)
IBS 0.703
Yes 3 (2.6) 4 (4.2) 7 (3.3)
No 113 (97.4) 91 (95.8) 204 (96.7)
MSC 0.589
Yes 1 (0.9) 2 (2.1) 3 (1.4)
No 115 (99.1) 93 (97.9) 208 (98.6)
Whiplash injury -
Yes - -
No 116 (100) 95 (100) 211 (100)
Anxiety/panic attack 0.042*
Yes 10 (8.6) 2 (2.1) 12 (5.7)
No 106 (91.4) 93 (97.9) 199 (94.3)
Depression 0.043*
Yes 12 (10.3) 3 (3.2) 15 (7.1)
No 104 (89.7) 92 (96.8) 196 (92.9)

Values are presented as mean±standard deviation, number (%), or median (interquartile range). axSpA: axial spondyloarthritis, NP: neuropathic pain, DN4: douleur neuropathique en 4 questions, FM: fibromyalgia, CSI-A: central sensitization A, CS: central sensitization, CSI-B: central sensitization B, RL: restless leg, CF: chronic fatigue, TMJ: temporomandibular joint, TTH: tension-type headache, IBS: irritable bowel syndrome, MCS: multiple chemicals sensitization. *Statistically significant (p<0.05).